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Some Reactions and Properties of Nitro
Radical-Anions Important in Biology and
Medicine
by Peter Wardman*
Nitroaromatic compounds, ArNO2 have widespread actual or potential use in medicine and cancer
therapy. There is direct proof that free-radical metabolites are involved in many applications, and an
appreciation ofthe conceptual basis for their therapeutic differential; however, an understanding of the
detailed mechanisms involved is lacking. Redox properties control most biological responses of nitro
compounds, and the characteristics of the one-electron couple: ArNO2/ArNO2 are detailed. The "futile
metabolism" of nitroaryl compounds characteristic of most aerobic nitroreductase systems reflects com-
petitioq between natural radical-decay pathways and a one-electron transfer reaction to yield superoxide
ion, 02- Prototropic properties control the rate ofradical decay, and redox properties control the rate Qf
electron transfer to 02 or other acceptors. There are clear parallels in the chemistry ofArNO2 and °2-
While nitro radicals have frequently been invoked as damaging species, they are very unreactive (except
as simple reductants). It seems likely that reductive metabolism of nitroaryl compounds, although gen-
erally involving nitro radical-anions as obligate intermediates (and this is required for therapeutic selec-
tivity towards anaerobes), results in biological damage via reductive metabolites ofhigherreduction order
than the one-electron product.
Introduction
Although the other papers in this issue attest to the
widespread interest in free-radical internediates in the
action of several classes of medically important com-
pounds, it is arguable that nitrocompounds are the one
class ofdrug in which direct proofofradical production
in intact target organisms has been demonstrated (1-
3) andinwhichthefree-radicalreactionalmostcertainly
responsible for the therapeutic selectivity has been ob-
serveddirectly(4). Thecombinationofidentification and
measurement ofsteady-state concentrations ofradicals
by electron spin resonance (ESR) and spectrophoto-
metric monitoring ofreaction kinetics following radical
generation by pulse radiolysis (5) has provided consid-
erable insight into the most important reactions and
properties of nitro radical-anions important in biology
and medicine.
Mason and colleagues (1-3,6-16) obtained high res-
olution ESR spectra of steady-state concentrations of
nitro radical-anions of a variety ofmedically-important
drugs in biological preparations:
"nitroreductases" -. ArNO-
and also established the concept (7,8) of"futile" reduc-
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tion or metabolism in aerobic conditions, where back-
oxidation occurs (4,17):
ArNO + 02 -- AxNO2 + 02 (2)
in competition with other one-electron transfer reac-
tions to appropriate electron-acceptors and with the
"natural" decay pathways such as disproportionation
(4,9,18-21):
2 ArNO- -* ArNO2 + ArNO2 (= ArNO) (3)
In this paper we restrict ourselves to considering ni-
troaromatic compounds, ArNO2; inthe absence of, e.g.,
substituents with basic functions, the one-electron ad-
ductsArNO2" are normally radical-anions atphysiolog-
ical pH because the pKa for the dissociation:
ArNO2H * ArNO + H+ (4)
is usually << 7(20,22-24). However, pH and pK4 gen-
erally defines the rate of reaction (3) (18,21,24), and
these properties are important in other electron-trans-
fer reactions.
Although there may be little or no net nitroreduction
in aerobic systems because of reaction (2), there may
be astimulation ofrespiration, afeature whichBiaglow,
Durand, Sutherland, et al. (25-29) recognized may beP. WARDMAN
important in the potentially widespread use ofnitroaryl
compounds in cancer therapy (31-34). The oxygen ten-
sion in tumor cells may control the radiotherapeutic
response, and nitro compounds (and otheroxidants) are
able to sensitize hypoxic cells to radiation, with a neg-
ligible effect on the radiosensitivity ofwell-oxygenated
tissues. In addition to this application, there is consid-
erable interest in combination chemotherapy involving
nitro compounds, or "chemosensitization" (33,34).
There is currently much interest (35) in the enzyme,
superoxide dismutase and the possible toxic properties
of 02, or, more plausibly, subsequent products ob-
tained via metal-catalyzed Fenton-type chemistry (36)
and in the invoking of"redox cycling" (37) [reactions (1)
and (2)] in the analogous chemistry with anthracyclines
and other quinones. Since the flux of O2- is stimulated
by most nitro compounds via reaction (2), one might
have expected the biological properties of nitro com-
pounds to reflect possible "superoxide" toxicity. How-
ever, mostnitrocompoundsarelesstoxictowardsmam-
malian cells in air than in hypoxia (38-40), which must
reflect the much more damaging, competing reactions
such as (3) and subsequent reductive pathways. The
detailsofthemechanismoftoxicityofantiparasiticnitro
compounds is the subject of an article by Moreno and
Docampo in this issue (41), and the present paper is
restricted tothemore basic chemical properties ofnitro
radical-anions which control the rate of reactions (1)-
(3) and hence their biological properties.
Nitroimidazoles aretheclassofnitrocompoundsmost
widely used in medicine, and the review ofJosephy and
Mason (42) covers the literature on the reduction prod-
ucts of nitroimidazoles to 1982. More recent work has
provided further information, e.g., on the instability of
reduction intermediates (43,44) and the reaction of re-
ductive fragments with glutathione (45), nucleosides
(46), and protein (47,48). Although there is much em-
phasis on higher reduction, the nitro radical-anion is
thought to be the obligate intermediate involved in ni-
troreduction by most (but not all) organisms, and its
radical chemistry is therefore central to the use ofnitro
compounds in medicine.
Redox Properties of Nitroaromatic
Compounds
Most biological properties ofnitroaryl compounds re-
flect the ease ofnitroreduction in a remarkably similar
way(28,49,50), althoughtheapparentsimplicityofmost
redox dependences isunfortunately notextended tothe
organisms ofmost interest in medicine (51-53). Hence
the thermodynamic parameter characterizing the rela-
tive ease ofreduction is ofmajorimportance in defining
the likely biological properties of different nitro com-
pounds; in fact, the parameter also controls the rate of
reaction (2), and other reactions with electron accep-
tors, as well as (1). Reaction (1) involves the one-elec-
tron couple: ArNO2/ArNO2L, and it is the reduction
potential E of this couple in water at physiological pH
which is the most appropriate index ofthe redox prop-
erties of nitroaromatic compounds in the present con-
text.
Since ArNO2- is unstable in aqueous solution at pH
- 7 (see below), conventional electrochemical measure-
ments such as polarographic half-wave potentials, E1/2
cannot be equated with potentials for the one-electron
couple, E(ArNO2/ArNO21). However, electrochemical
measurements of E½ using, e.g., cyclic voltametry in
aprotic solvents (54) orpolarography in water (55) gen-
erally parallel the thermodynamically reversible one-
electronpotentials inwateratpH 7suchthatthe values
are numerically similar when E is expressed on the
hydrogen scale (NHE) and E½ on the calomel reference
(SCE). Thus, generally, E (E½ - 0.24 V) to a fair
approximation. The higher the value (more positive),
the more electron-affinic (more powerful oxidant) the
nitro compound.
The most powerful and reliable method to determine
E(ArNO2/ArNO2-) is from pulse radiolysis measure-
ments of the equilibrium constant for one-electron
transfer equilibria involving ArNO2 and a reference
compound of known reduction potential such as a qui-
none or bipyridinium compound (56,57):
ArNO- + Q ;± ArNO2 + Q
since
AE5 = E(QIQ ) - E(ArNO2/ArNO2 )
E(ArNO2/ArNO- ) = E(Q/Q ) - (RT/F) ln K5
(5)
(6)
(7)
E(ArNO2/MANO2 )
- E(Q/Q ) - 0.059 log K5 (8)
ifE is in volts. The yields and reactions of the species
produced upon radiolysis of aqueous solutions are so
well established that the design ofsuch experiments is
a matter of routine (5). The radicals: ArNO21, Q are
usually generated within a microsecond or so ofthe end
of a radiolysis pulse of equally short duration, and the
equilibrium (5) attained andthe equilibriumconstantK5
measured spectrophotometrically within (typically) 10-
200 ,usec, i.e., before the unstable radicals can decay
via routes such as (3) (5,56,57).
A scale ofreduction potential spanning the range ap-
propriate for virtually all nitroaryl compounds of med-
ical or biological interest is shown in Figure 1. The
potentials of three common nitroheterocycic pharma-
ceuticals are seen to be significantly lower than that of
oxygen. [Note: E(02/02-) is correctly given as -0.33
V vs. NHE at pH 7, since the thermodynamic standard
state for oxygen is unit fugacity, i.e., 1 atmosphere
pressure. Useofthe Nernstrelationshipandconverting
to a nonstandard state of 1 mole/dn3 O2/O2- (the same
standard state as ArNO2/ArNO2t) gives an effective
E(02/02-) ofca. -0.15 V, a value more appropriate for
direct comparison with E(ArNO2/ArNO2 ] (58).
Also shown in Figure 1 are the potentials of com-
pounds which illustrate the effects of additional, elec-
tron-withdrawing substituents in (in this case) the 2-
nitroimidazole ring system. Such effects can be readily
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N2)CH3
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1
misonidazole
metronidazole
Table 1. Values of reduction potential and equilibrium constants
for electron-electron transfer to oxygen for some biologically
important nitroaryl conopounds.
additional electron-
attracting groups
increase electron
affinity
t
oxygen
nitrofurantoin
FIGURE.1. Scale of reduction potential of the couple: ArNO2/Ar-
NO2- (vs. the normal hydrogen electrode NHE). The positions of
some common drugs are indicated, together with those of the 4-
nitro analog of misonidazole and some 2-nitroimidazoles with ad-
ditional electron-withdrawing groups to illustrate the effects of
these variables. The value for oxygen has been adjusted to refer
to 1 mole/dm3 02 rather than 1 atmosphere 02 (see text).
E(ArNO2/ArNO27)/V
Compound vs. NHE K2
4-Nitroquinoline-N-oxide - 0.175 2.2
Nifurpipone -0.214 10
Furaldatone - 0.248 37
Nitrofurazone - 0.257 53
Nitrofurantoin - 0.264 70
Furaspor - 0.338 1.2 x 103
Ro 03-8799 - 0.346 1.7 x 103
Benznidazole - 0.380 6.4 x 103
SR-2508 -0.388 8.8 x 103
Misonidazole -0.389 9.1 x 103
Niridazole - 0.390 9.5 x 103
Moxnidazole - 0.410 2.1 x 104
Azomycin - 0.418 2.8 x 104
4-Nitrobenzoic acid - 0.425 3.7 x 104
Nimorazole - 0.457 1.3 x 105
Tinidazole - 0.464 1.7 x 105
Flunidazole - 0.467 1.9 x 105
Ronidazole - 0.475 2.6 x 105
Panidazole - 0.475 2.6 x 105
Dimetridazole -0.475 2.6 x 105
Metronidazole - 0.486 4.0 x 105
predicted once the potentials oftwo orthree compounds
in a given series have been measured, using predictive
relationships based upon Hammett substituent con-
stants (59). Thus for 5(R)-1-methyl-2-nitroimidazoles:
ElV -0.406 + 0.146 (R)
and for 4(R) -nitrobenzenes:
ElV -0.484 + 0.168 (R)
(9)
(10)
in water at pH 7,
- 298°K.
Figure 2 illustrates the variation ofestimated values
of E(ArNO2/ArNO2-) (under physiological conditions)
for some of the more common nitroaryl ring systems,
and Table 1 lists values ofE for the compounds ofmost
interest in biology, medicine, and cancer therapy. [The
author is preparing a more complete compilation of re-
duction potentials of couples involving free radicals in
aqueous solutions, to be published in the U.S. National
Standard Reference Data Series, which will give full
details and a bibliography; most of the values shown
have been published in a variety of references (4, 20,
30,49, 53, 56, 57).]
The position of the important one-electron transfer
equilibrium (2):
ArNO2 + 02 i ArNO2 + 02'
QNO2
-0 33 V
-0 N02
-0-39
R R
JNO2 02N N
-0-39 -0-56
NO2 NO2
-0-49 -0-19
O C02-
HNA N02 HNcN02
)lN dJ0 NCo
-0-53 -0-59
R
NO2
aN ON°2 (
o0
-0 30 -0-18
7NO2
H
-0-57
R
02NC )
N
-0 47
QNO2
-0-4
R
02N
-0-56
0 CH3
H3
oN N
CH3
-0-21
(2)
can be simply calculated from these values ofE and the
relationship:
log K2
-
{-0.155 - [E(ArNO2/ArNO2 )]/V}/0.059 (11)
FIGURE 2.. Estimated values of reduction potential, E(ArNO2/
ArNO2) vs. NHE in water at pH 7 of some typical nitroaryl
systems. The examples are based upon measurements ofthe com-
pounds or simple derivatives where R = alkyl or hydroxyalkyl,
etc., and the values may be significantly different when additional
ring substituents are present (see Fig. 1).
1
I I I I I
-0-6 -0-5 -Q04 -0Q3 -0-2 -0-1
reduction potential, EI/V (-p- increasing
electron affinity )
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Estimates ofK2 are included in Table 1.
The positions of other electron-transfer equilibria of
interest may be calculated similarly, replacing Q/Q- by
the appropriate couple in eq. (5) and using the relation-
ship (8). Thus ascorbate, AH- has frequently been of
interest as a potential electron donor to nitroaryl com-
pounds, e.g., with4-nitroquinoline-N-oxide (27, 60-63):
ArNO2 + AH- ± ArNO- + AH (A + H+) (12)
The reduction potential ofthe ascorbyl radical at pH 7,
E(AH/AH-) can be estimated reliably at 0.30 V vs.
NHE from either measurements ofone-electron trans-
fer equilibria at pH 13.5 (64) or calculations (65) based
upon the semiquinone formation constant from ESR
measurements (66). Hence:
log K12- {[E(ArNO2/ArNO- )]/V - 0.30}1/0.059 (13)
andK12is estimated tobe 9 x 10-9for4-nitroquinoline-
N-oxide, 3 x 10-10 for typical 5-nitrofurans, 2 x 10-12
for simple 2-nitroimidazoles and 5 x 10-14 for metron-
idazole and analogs. These equilibria are, ofcourse, pH-
dependentsinceE(AH/AH-)isdecreased, e.g., to0.015
V at pH 13.5 (64), at which pH K12 is increased to ca.
1 X 10-7 for simple 2-nitroimidazoles.
In spite ofequilibrium (12) being thermodynamically
so unfavorable (K12 < 10-8 even for the most electron-
affinic nitro compound), abscorbate can still be a poten-
tial one-electron reductant because the products of re-
action (12) are unstable and are being continuously re-
moved by, e.g., disproportionation or reaction (3). A
further reaction may also be considered. The one-elec-
tron reduction potentials for addition to a second elec-
tron to nitroaryl compounds [the reduction potential of
the nitro radical-anion, E(ArNO2"/ArNO22-) or
E(ArNO2"/ArNO)] are unknown for aqueous solutions
at pH 7, although there is some evidence (see below)
thatArNO21 is a poorer oxidant than O2- atphysiolog-
ical pH; apparently ArNO21 is unable to oxidize the
Cu(I) formofCu-Znsuperoxidedismutase, whereasO2-
is able to do so (67). However, it is not inconceivable
thatoxidation ofAH- byArNO2' mayplay asignificant
role; the reaction would be expected to be at least as
complex astheanalogous oxidationbyO2- (68). Indirect
evidence for nitro radical formation from a nitrofuran
with ascorbate (pH 7) as electron donor has been ob-
tained (63), making use of a diagnostic cis-trans chain
isomerization reaction (69,70) which yields up to
- 200
molecules isomerized per radical-anion produced (71)
(see below):
cis -AF -2 + "nitroreductases" -- trans -AF -2 (14)
Similar considerations apply to the thermodynamics
of formation of nitro radical-anions from other reduc-
tants, e.g. reduced flavin, FMNH2:
ArNO2 + FMNH2 a± ArNO; + FMNH (+H+).
Using a value ofE(FMN/FMNH) = -0.124 V (72), we
have
log K15 = {([E(ArNO2/ArNO2 )]/V+ 0.124)}/0.059 (16)
andK15is estimated to be 8 x 10-6 for4-nitrobenzoate
atpH7. Again, inspiteofunfavorablethernodynamics,
FMNH2 reduces many ArNO2 at readily measurable
(and redox-controlled) rates (73), and FMN + NADH
generates steady-state concentrations ofArNO2' which
are detectable by ESR (7).
These calculations are valid only for pH 7, since the
potentials of both couples may vary with pH. In the
case ofthe couple, ArNO2 , the potential Ei at any pH
= i may be calculated from:
Et
= E7 + 0.059 log {[K4 + [H+]i]I[K4 + 10-7]} (17)
provided there are no additional substituents with pro-
totropic properties. Since pK4 < 7 forall known, simple
nitroaryl compounds (see below), this pH dependence
ofE(ArNO2/ArNO2-) is frequently unimportant in re-
spect of physiological conditions. However, acidic or
basic substituents complicate the issue considerably
(24,56,57,59).
A note of caution is also appropriate concerning the
rates of reactions which may have readily calculable
thernodynamic parameters but which are catalyzed
eitherbyenzymesinvitro orevenbysimple, freemetal
ions. The reduction of ArNO2 by flavins or thiols are
catalyzed by trace quantities ofFe(II) (63,73-76). One-
electron reduction by free thiols is thermodynamically
much less favorable than by ascorbate, since E(RS/
RS-) must be much more positive than E(A/AH-) at
pH-7, indeed higher than E(PZ+)/PZ) 0.8-0.9 V
where PZ = common phenothiazines (77).
Prototropic Properties of Nitro
Radical-Anions
Inadditiontobeingofpotentialimportanceindefining
the pH-dependence of redox properties, prototropic
equilibria control the natural lifetimes ofnitroaryl rad-
ical-anions in aqueous solution. Equilibrium (4) is writ-
ten as a dissociation ofan oxygen acid, but protonation
at sites other than oxygen may be important, so that
Eq. (18) may be considered a general representation,
of which Eq. (4) is a specific example.
(ArNO2 )H' +± ArNO + H+ (18)
Grunbein et al. (22) estimated the values ofpK4 (pK18)
of 17 nitrobenzene derivatives from the pH-dependent
absorption spectra of the radicals produced upon one-
electron reduction by pulse radiolysis. The measure-
ments ofpK4spannedtherange2.2(1,2-dinitrobenzene)
to 3.9 (1-ethoxy-2-nitrobenzene); since only one deriv-
ative had any other prototropic functions (3-nitroben-
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zoic acid), the values must represent protonation at ox-
ygen, equilibrium (4). The effects of different
substituents uponpK4 [= 3.2fornitrobenzene (18)] cor-
related well with Hammett a substituent constants, in
turn reflecting the spin density on the nitro group in
the radical (56). Published estimates ofpK4 for 12 sub-
stituted nitrobenzenes (18,20,22,78), together with val-
ues of E at pH 7 (20,56,73,79) yields:
pK4 = (0.61 + 0.23)-(5.2 + 0.6)(E/V) (19)
This relationship, ifit were applicable to heterocycles
such as 5-nitrofurans or nitroimidazoles, would predict
values of pK4 in the region of <2, ca. 2.7 and 3.2 for
typical 5-nitrofurans, 2- and 5-nitroimidazoles respec-
tively. Values of pK4 as low as 1-1.2 for 5-nitrofurans
have been reported (23), but prototropic dissociations
with pK = 5.7 or 6.1 were reliably characterized for
the nitroimidazoles, misonidazole, and metronidazole,
respectively (24). These latter values must reflect pro-
tonation on the unsubstituted imidazolyl nitrogen in
these molecules and not on the nitro group, a view sup-
ported by the symmetrical ESR hyperfine pattern re-
cordedontheunsubstituted2-nitroimidazole(azomycin)
radical-anion (80).
Thus even simple nitroimidazole radicals have two
sites for protonation in the readily-accessible range of
pH: N02 oxygen and ring nitrogen. When ring substi-
tuents carry groups with prototropic properties, e.g.,
nitrogenous bases or carboxylic acids, the pKa for dis-
sociation ofthese additional proton sites may be signif-
icantly different in the ground state and radical even
when, e.g., the side-chain nitrogen is "insulated" from
the nitroaryl ring by a 2- or 3-carbon aliphatic chain. A
typical example in the important 2-nitro-1-imidazolyl-
alkylamine series has been discussed (59). More dra-
matic shifts in pKa between ground state and one-elec-
tron adduct are found with the protonation of the un-
substituted (N-3) imidazolyl nitrogen in some simple N-
1 alkyl/alkanol substituted 2-, 4- and 5-nitroimidazoles,
where the increase in pKa upon electron addition is
around 6.2, 5.5, and 3.6units, respectively (24,81). ESR
studies have characterized the dissociation ofacidic ring
N-H protons in other nitroaryl radical-anions lacking
carbon substitution at nitrogen (80,82).
Natural Lifetimes of Nitro-Radical
Anions
The normal decay pathway of most nitro radical-an-
ions at pH
- 7 in water is that of second-order dispro-
portionation:
2 ArNO0 + 2 H+ -* ArNO2 + ArNO + H20 (20)
However, there are two major complications and at
least one important exception to this rule. Firstly, the
formation of the nitroso compound, ArNO occurs (at
least in the case of nitrobenzene) via a hydrated form
which dissociates in anacid-catalyzed reaction (18). Sec-
ondly, Eq. (20) includes the involvement of protons in
the overall reactions, and there are three distinct re-
action pathways which must be considered, precisely
analogous to the disproportionation ofHO/O- to yield
H202 (83):
2 ArNO2H -* ArNO2 + ArNO (+ H20) (21)
ArNO2H' + ArNO- (+ H+)-ArNO2 + ArNO(+ H+) (22)
2 ArNO- (+ 2H+) -- ArNO2 + ArNO (+ H20) (23)
As with O21, it appears that ArNO2- does not react
with itself in water at a significant rate, i.e., k2- 0,
except in the case of 4-nitroacetophenone (4). The ki-
netics then simplifies to:
2kobs = [2k21 + 2k22(K18/[H+])]/(1 + K18/[H+])2 (24)
where the rate equation is defined as:
-d[ArNOl/Idt = 2kobs [ArNO 12 (25)
and the half-life at any initial concentration [ArNO21]0
is given by:
tl/2 = 1 kob8[AxNO2 ]o (26)
Figure 3 illustrates the typical, pH-dependent sec-
ond-order rate constant for the decay ofmetronidazole
radicals measured by pulse radiolysis. More extensive
studies (21) using pH 7.4, isotonic ionic strength,
-
2980K, have proven the radicals decay by accurate sec-
ond-order kinetics with2kobs = 4.2 x 104dm3/mole-sec
under these conditions. The values for radicals from
other 5-nitroimidazoles such as ornidazole and nimora-
zolewerewithin afactoroftwoofthatformetronidazole
(21), and independent ESR observations ofthe dispro-
portionate rate of 4-nitrobenzoate radicals at RH 7.4
gave a value of2kob8 [eq. (25)] = 8.5 x 103 dmi/mole-
sec (9,84)]. More extensive, pulse radiolysis measure-
mentsofsubstituted nitrobenzeneradicals(20)provided
estimates of2kobh at pH 7 in the range 7 x 104 to 3.3
x 108 dm3/mole-sec, although most were < 107 dm3/
mole-sec (values at pH 7.4 would be expected to be 2.5
times lower than those at pH 7). The decay kinetics of
some other nitroimidazole radicals (e.f., 5-chloro-1-
methyl-4-nitroimidazole, 2kob8 = 1 x 10 dm3/mole-sec
at pH 7) (81), but not 2-nitroimidazole radicals (21) are
broadly similar to those illustrated in Figure_3 for me-
tronidazole. A value for 2kob8 5 x 10 dm3/mole-sec
can be considered typical for the decay of most simple
nitro radicals under physiological conditions.
The steady-state concentrations of nitro radicals can
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STABILITY OF NITRO
RADICALS (2nd order decoy \ 0
constants)
pH 8 9
FIGURE 3. Decay kinetics of the radical-anions ofmetronidazole or
4-nitroacetophenone in water at 298°K as a function of pH (ionic
strength = 0.3). The values for metronidazole at pH > 6 are
probably upper limits; the more extensive studies (21) give values
of 2k relevant to physiological conditions which supercede the
results of this preliminary study shown here.
other observations (see below). The dependence ofthe
steady-state concentration ofradicalsonthe squareroot
of the (reductase) protein concentration (3,9,10,13,16)
indicates the general second-order decay pathway, Eq.
(20), is common to nitrobenzenes, -furans, and -imida-
zoles (except 2-nitroimidazoles).
The pH-dependent lifetimes shown in Figure 3 raise
an interesting point. That the transition in the value for
2kob8 for 4-nitroacetophenone radicals occurs at a pH
significantly higher than pK4 (= 2.7 (77)) reflects the
relative values: k?2 > k2l, a similar situation to that
seen with HOW/O2 (83).
Electron-Transfer Reactions of Nitro
Radical-Anions
The values ofthe couple: E(ArNO2/ArNO2!) may be
used to assess not only the thermodynamic feasibility
of one-electron reduction of ArNO2 by any potential
"nitroreductase" (flavin, ascorbate, Fe/S protein, etc.)
butalsothelikelihood ofelectrondonationfromArNO2-
to potential acceptors. In the present context the most
important of these is obviously oxygen [reaction, (2)].
Equation (11) defines the position of equilibrium but
says nothing about the kinetics of reaction (2) in par-
ticular:
ArNO` + 02 --ArNO2 + 02
be measured by ESR and are typically of the order of
1 ,umole/dm3 in many experiments (7,9). The concen-
trations in intact, target organisms depend on the sub-
strate (2) andlikelyinvivovalues aredifficult topredict.
However, typical natural lifetimes [with respect to de-
cay by reaction (20) only] of nitro radicals under phys-
iological conditions could well be as long as 20 sec [from
Eq. (26), using a steady-state concentration of 1 ,umole/
di3 and 2kob8 = 5 x 104 dm3/mole-sec].
These calculations can not be applied to the radicals
from 2-nitroimidazoles, which decay in an unknown,
first-order pathway which is, nonetheless, still first-or-
der in [H+]:
ArNO" (+ H') -+ products
Direct measurements of the kinetics of this reaction
for numerous nitroaryl compounds have been made, il-
lustrating the expected, Marcus-type redox depen-
dence; the initial report (4) provides a typical cross sec-
tion. Values ofk2 at 298°K range from about 4 x 107
dm3/mole-sec for compounds with E
- -0.6 V (e.g., 5-
nitroorotic acid), 7 x 106 dm3/mole-sec for E
- -0.5 V
(e.g., metronidazole), 4 x 106 dm3/mole-sec for E
-
-
0.4 V (e.g., misonidazole) to 2-3 x 105 dm3/mole-sec for
typical 5-nitrofurans with E
- -0.25V. The Arrhenius
parameters have been measured for six typical com-
pounds (P. Wardman and E. D. Clarke, unpublished):
k = A exp{-Ea/RT (28)
(27)
with -d[ArNO2-]/dt = k27 [ArNO2-], and k27 around 5-
10/sec at pH 7.4 for simple 2-nitroimidazoles (21). The
natural lifetimes of 2-nitroimidazole radicals are thus
independent oftheir steady-state concentration, within
a sensible physiological range (21), and are around 0.1 sec
at pH 7.4 (= In 2/k27).
Lifetimes ofnitroimidazole radicals are many seconds
at high pH (4,21,24,81), similar to the behavior of rad-
icals from nitrobenzene and derivatives (18,19,85,86).
A report (23) that the second-order rate constant for
the decay of the 5-nitrofuroic acid radical anion re-
mained essentially unchanged (2k = 2.2 x 109 dm3/
mole-sec) from pH 10.5 to 3.3 is completely inconsistent
inboth magnitude andpH-independence with numerous
with Ea all in the range 30-39 kJ/mole; the algorithms
for the temperature dependences of k2 for metronida-
zole and misonidazole have been reported (4,21).
There seems no question that the product ofreaction
(2)isindeed 02- withrestorationofArNO2. Preliminary
spectral evidence that O2- is a product (4) is substan-
tiated by the spectra shown in Figure 4, which are the
results of repeating the earlier work (4) with further
precautions taken to eliminate artefacts from scattered
light (or at least, to ensure identical artefacts in the
control spectrum of 021). Pulse radiolysis measure-
ments always measure the change in absorbance intro-
duced by the conversion ofground state to radical; that
the final spectrum in Figure 4 agrees with that of 02-
requires restoration ofthe nitro radical to ground state,
(2)
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FIGURE 4. Absorbance changes recorded upon pulse radiolysis (18
Gy, 2 ,usec) of a solute containingmetronidazole (0.4 mmole/dm3),
oxygen (0.26 mmole/dmO), formate (0.1 mole/dm3) and Na2HP04
(2mmole/dm8, pH 8.3). Spectra recorded at 10 p,sec (0) Qr25 msec
(LI) afterthepulse. Thebrokenlineisthespectrum of02 obtained
upon radiolysis of a similar solution without metronidazole, but
using an (unirradiated) solution filtercontainingmetronidazole be-
fore the monochromator to ensure any small spectral distortions
or artefacts from scattered light were similar in the two experi-
ments (the solution transmitted only ca. 2% of the inci(Ient light
at 270 nm). The initial absorbance at 425 nn (where °2 does nQt
absorb) was 47% ofthat ofasimilar 02-free solution (onlyArNO2 )
and the solid line through the 10 psec points is the calculated
spectrum, based upon independent experiments, of the mixture
of 47% ArNO2 and 53% 02 present at 10 .sec. Absorbance is
recorded as the product of G (molecule/ 100 eV) and extinction
coefficient, e (dm3/mole-cm). Yield: 0.1036 p,mole/J equivalent to
1 molec/100 eV. In experiments designed to measure k2, a higher
value of[ArNO2] wouldbe used togreatly increase theinitialratio
of[ArNO21)]: [Ot which wasunavoidablylowinthisexperiment
to permit adequate light transmission at >300 nm.
which absorbs strongly in this spectral region. ESR
spin-trapping of O2- (17) provides further evidence that
O2- is a product.
Since an earlier report (87) indicated a rate constant
for reaction of the nifuroxime radical-anion around 4
ordersofmagnitudehigherthan ourvalue(4)(andabout
50-fold higher than that for any other nitro compound
so far reported, let alone for a compound with high
electron affinity, i.e., with relatively low "driving en-
ergy"), it seems appropriate to present some raw data
to justify our claim. Figure 5 shows the absorption
changes produced upon generating the nitro radical in
N2,-, air- or 02-saturated solutions offormate (to scav-
enge H and OH) (5); tert-butanol, an alternative OH
scavenger was used by Greenstock and Dunlop (87).
There arerapidspectralchangesinthetert-butanol sys-
tem, presumably resulting from reaction oftert-butanol
radicals with nifuroxime, or radical-radical reactions;
the natural lifetimes ofsimple nitroradicals arewithout
exception much longer than implied by the data of
Greenstock and Dunlop (87). Although the first-order
dependence of radical decay on oxygen concentration
reported by Greenstock and Dunlop is impressive, it
appears that the tert-butanol system is not satisfactory
for studying reaction (2) in this instance.
Since the reduction potential, E of even the most
electron-affinic nitroaryl compound so far reported (4-
FIGURE 5. Absorbance changes at 400 nm recorded upon pulse ra-
diolysis (8.7-12.3 Gy, 0.2 ,sec) ofsolutions containing nifuroxime
(0.5 mmole/dm3), formate (0.2 mole/dm3) and phosphate (4 mmole/
dm3, pH = 7.3). The solutions were either N2-, air- or 02-satu-
rated, as shown. The rate constant k2reported by Greenstockand
Dunlop (87) would require a half-life for decay of ca. 0.4 ,sec in
02-saturated solution, about4 orders ofmagnitude fasterthanthe
decay shown above. The scale of absorbance per unit centimeter
pathlength is shown (a 2-cm cell was used.).
nitroquinoline-N-oxide) is -0.18 V, it is not surprising
that electron transfer from nitro radicals to more pow-
erful oxidants such as Fe(III) or Cu(II) is at rates ap-
proachingthediffusion-controlledlimit. ThusforArNO2
= misonidazole or 5-chloro-1-methyl-4-nitroimidazole:
ArNO + Fe(CN) -- ArNO2 + Fe(CN)64- (29)
has k29 = 2.3 x 108 and 3.6 x 108 dm3/mole-sec, re-
spectively at zero ionic strength and room temperature
(24,81) (both values would be ca. 1 x 109 dm3/mole-sec
in isotonic saline). Electron transfer from ArNO21 to
Fe(III)-cytochrome c has rate constants of the same
order (88).
Reaction of ArNO21 with Cu(II) is interesting be-
cause of the importance of this center in superoxide
dismutase:
ArNO- + Cu(II) -* ArNO2 + Cu(I) (30)
With 4-nitroacetophenone and Cu(H2O)62+, k30 = 1.4
x 109 dm3/mole-sec at low ionic strength, decreasing
by an order ofmagnitude or more when Cu(II) is com-
plexed to glycine, tryptophan, etc. (67). A relatively
slow reaction of the metronidazole radical-anion with
Cu(II) superoxide dismutase was recorded (k30 7 x
106 dm3/mole-sec), but the Cu(II) was essentially inac-
tivated in the reaction, i.e., the type of oxidative, res-
toration reaction essential to the catalytic reaction with
O2- was not, apparently, favored with ArNO21 (67):
ArNO + Cu(I) -4 ArNO2 + Cu(II) (31)
These studiesnonethelessindicatedthatsuperoxidedis-
mutase was not inert to electron donors such as some
_t _ ..(All400 nm, pH 7-3)
N; 8-7Gy
20ms i
A =0-0040km
T
air 8*1 Gy
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semiquinones or nitro radical-anions.
The kinetics of electron transfer reactions between
ArNO2/ArNO2- and otheroxidant/radicalcouples ofnot
too dissimilar reduction potential, e.g., quinones
(56,57,80) follow the well-established Marcus-type re-
lationships between the rate constant and free energy
(89). Conceptually the simplest electron-transfer reac-
tion is electron exchange between radical-anions and
ground states of different (or indeed the same) nitro
species:
(ArNO2 )a + (AINO2)b ± (AxNO2)a + (AxNO )b (32)
Measurements by Dr. I. Wilson (personal communica-
tion) for AE = -0.36 to 0.2 V yield:
log(k32/dm3/mole-sec)
= 11 - 4.90 (1 - 0.86AE)2 (33)
Thus the radical-anions of nitrobenzyl halides undergo
intramolecular electron-transfer to yield nitrobenzyl
radicals and halide ions (91):
p -N02(C6H4)CH2Br -- p -NO2(C6H4)CH% + Br- (37)
with k37 = 1.7 x 105/sec. Similar behavior is seen with
5- and 8-(halomethyl)-1-nitronaphthalenes and with (4-
nitrobenzyl)tosyl derivatives (92). However, 4-haloni-
trobenzene radical-anions decay via second-order ki-
netics (with k for halide elimination < 1/sec) (93), and
the radical-ion of 4-chloro-1-methyl-5-nitroimidazole is
similarly long-lived (81). In spite ofthe apparently nor-
mal disproportionation behavior of the latter radical,
significant yields ofhalide ion are eventually produced
(at times > 1 sec) following one-electron reduction of
this ring-halogenated nitroimidazole (81) and analogs
(94).
where
AE = E(ArNO2/ArNO2 )b -E(ArNO2/ArNO -)a (34)
When AE = 0, k32 = 1.3 x 106 dm3/mole-sec, a value
around 40-fold slower than the corresponding zero-en-
ergy electron-exchange rate with quinones/semiqui-
nones (89) in aqueous solution.
Reaction(32)isthebasis forthefacile, chaincis/trans
isomerization of the (5-nitro-2-furyl)acrylamide, AF-2,
known to occur via nitro radical anion intermediates
(11,13,63,69-71). The chain reaction arises because the
reduction potential of the trans/trans couple is
- 34
mV lower than that ofthe cis/cis" couple; the chain is
propagated via:
trans + cis -- trans + cis- (35)
competing efficiently with:
cs- transm
since ks5 = 2 x 106 dm3/mole - sec and k36 5 - 40/
sec (71). When AF-2 is used as an indicator of "nitro-
reductase"activitywithothernitroaromaticcompounds
alsopresent, competingforthe (enzyme) electrondonor
(90), the electron exchange reaction (35) can occur in
competition with Eqs. (36) and (2), and the redox-re-
lated competition is a reflection ofall ofthese reactions
and notjust the relative efficiency ofelectron donation
from the enzyme (71).
All the electron-transfer reactions-(27), (29)-(32),
and (35)-are typical of intermolecular reactions, of
which both the positions of equilibria and the approxi-
mate rate constant can be predicted with reasonable
confidence, providing estimates are available ofthe re-
duction potentials of the donor and acceptor couples.
However, intramolecular electron transfer may well be
important in particular, substituted nitroaryl radicals.
Competition between "Natural"
Decay Pathways and Electron-
Transfer Reactions
Perhaps the most important electron-transfer reac-
tion ofArNO2Lis with 02 as electron acceptor, reaction
(2). Competition betweenEqs. (2)andthenaturaldecay
pathway (3) or, in some instances, unknown routes rep-
resented by Eq. (27) is easily quantified, although it
should not be forgotten that other, high-potential elec-
tron sinks in addition to02maywell beimportantdecay
routes: Fe(III)-cytochromes, flavoproteins, etc. It is
easily seen that the ratio of decay pathways: (rate of
restitution by O2)/(rate ofsecond-order decay) is given
bythe function: (k202])/2k3[ArNO21]). Taking metron-
idazole as a typical example, with k2 = 7.4 x 106 dm3/
mole-sec and 2k3 = 4.2 x 104 dm3/mole-sec at 298°K,
pH 7.4 (see above), we have:
rate of restitution 200 x 102]/[ArNO] (38)
rate of decay
where [ArNO2'] is the value at a steady state. If this
is ofthe order ofmicromolar, (see above) then Eq. (38)
becomes:
rate of restitution
rae o y 200 x ([02]mole/dm3)
rate of decay (39)
and even submicromolar levels of 02 (continually re-
plenished) will be sufficient to inhibit nitroreduction
very efficiently if other decay pathways are not avail-
able.
Just such a simple situation was modeled by Rauth
et al. (95), producing metronidazole radical-anions ra-
diolytically at a zero-order rate ofca. 10 nmole/dm3-sec
in the presence oflow concentrations of02. They found
that e.g., 100 ppm 02 (gas phase; ca. 120 nmole/dm3 02
in solution) was sufficient to inhibit nitroreduction al-
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mostcompletely. Usingthesteady-stateapproximation:
rateofproductionofArNO2- = rateofdecay, itiseasily
calcuated that the steady-state concentration of nitro
radical-anionisca. 11nmole/dm3underthese conditions.
Then, from Eq. (38), a ratio: rate ofrestitution/rate of
decay 2000 is expected.
In the same study, it was found that 02 inhibited
nitroreduction of four typical 2-nitroimidazoles very
much less efficiently than the effect on the reduction of
metronidazole or 4-nitroacetophenone. Thus ca. 2-7
,umole/dm3 02 was required to inhibit effectively the
reduction ofthe 2-nitroimidazoles. The authors pointed
out (95) that the differences could arise if there was a
first-order pathway for "natural" decay, as indeed had
been observed experimentally (21). If the competing
reactions are those of Eqs. (2) and (27) with (e.g., mi-
sonidazole) k2 = 4.2 x 106 dm3/mole-sec andk23 = 10/
sec, then an 02 concentration ofca. 20 ,umole/dm would
berequired forthe rate ofEq. (2) to be tentimes faster
than the rate of Eq. (27).
Some Other Reactions of Nitro
Radicals
ThepH-dependentdecayofArNO2' viareactions(21)
and (22) is exactly analogous to the decay of 02- in
aqueous solutions (82), and it is instructive to consider
other possible reactions of ArNO2- within the frame-
work of the known chemistry of O2.- One-electron re-
duction of several classes of oxidant yields radicals
which aremorepowerful oxidantsthantheground state
at physiological pH. Examples include: quinones, flav-
ins, and oxygen itself. Alternative statements of this
generalization are: E(A/A-)<E(A-/A2-), where A is
the oxidant, or the semiquinone formation constant, Kf
= [AO]2/([A][A2-j) < 1. Thus O2- is a more powerful
oxidant than 02; however, as discussed above, ArNO2-
seems to be a much weaker oxidant than 02- since a
typical example cannot reoxidize Cu(I).
The reaction of 02- with thiols, RSH has been the
subject ofseveral studies (96,97), with the more direct
measurements(97)being(intheauthor'sview)themost
reliable, especially since the reaction is probably ther-
modynamically unfavorable (see below). Thus:
L-Cysteine + 0-°2products (40)
was estimated to have k4o < 15 ± 2 dm3/mole-sec at
pH 10.9(97). Onewouldexpectthereductionbythiolate
anions of the weaker oxidant, ArNO2' to be much
slower than this latter value. There is some evidence
(50,98) that the reduction potential, E(RS/RS-) does
not differ by more than 0.10-0.15 V for the common
thiols, so a study with one thiol should be reasonably
predictive ofthe behavior ofanother.
In spite ofthis background, and in spite of the total
lack of experimental demonstration, several authors
havepostulatedthattheprotectiveroleofthiolsin, e.g.,
the cytotoxicity ofnitroaryl compounds, arises from re-
action of ArNO2- with RSH/RS-, presumably the re-
action:
ArNO2 + RS- + 2 H+ -. ArNO +RS7 + H20 (41)
This reaction seems exceedingly unlikely thermodyn-
amically. Sincethiylradicals, RSoxidizephenothiazines
withk > 3 x 107dm3/mole-sec (77), E(RS/RS-)isprob-
ably > 1.1 V at pH= 3 and at least 0.9 V atypH 7,
(probably significantly higher). Since E(02-/02 ) =
0.865 V at pH 7 (58), reaction (40) is probably ther-
modynamically unfavorable. The coupleArNO21/ArNO
will only be reversible at high pH, but the difficulty in
oxidizingCu(I) points to its potentialbeing at least sev-
eral tenths of a volt lower than that of RS/RS-. Re-
action (41) thus seems most unfavorable, unless irrev-
ersibility facilitates the forward reaction. This analysis
is entirely consistent with two independent, experi-
mentalstudies. Polnaszeketal. (99)foundthat0.1 mole/
di3 glutathione (GSH) had noeffectonthe steady-state
concentration ofArNO2" produced via rat hepatic mi-
crosomal or xanthine oxidase reducing systems, using
three different 5-nitrofurans. The lifetime of misoni-
dazole or metronidazole radical-anions was not detect-
ably changed by the presence ofGSH (2 mmole/dm3) at
pH 7.3 or9.4 [thehigherpH should favorreaction (41)];
thus k41 < 5 dm3/mole-sec at pH 9.4 (21) and is very
probably < 0.05 dm3/mole-sec at pH 7.4.
The well-characterized reaction of nitrosoaryl com-
pounds with GSH (100) is, therefore, probably >6 or-
ders of magnitude faster than Eq. (41) and the most
likely explanation of the biological role of GSH in ni-
troaryl cytotoxicity, etc. However, nitroaryl com-
pounds, when coreduced with DNA, do cause extensive
damage to the macromolecule (101) in spite ofa lack of
effect of DNA, RNA, ribose, nucleotides or protein on
the steady-state concentration ofArNO21 in reductase
systems (99). We have failed to demonstrate any oxi-
dizing properties ofArNO2- with some ofthe most fa-
vorable possible reductants, e.g., N,N,N',N'-tetra-
methyl-p-phenylenediamine (TMPD) (50):
ArNOr + TMPD + 2 H+ 4 ArNO + TMPD+ + H20 (42)
Oxidation of e.g., guanine sites, G3 would be much less
favorable than Eq. (42) since E(G+/G) >> E(TMPD+/
TMPD). We have speculated that nitroso radicals could
be more powerful oxidants than ArNO21 (50), since ni-
trosobenzene is a more powerful oxidant than nitroben-
zene (18):
ArNO + ArNO - ArNO2 + ArNO, (43)
and indeed than oxygen (30):
02 + ArNO -02 +ArNO (44)
withkv = 4.1 x i07 dm3/mole-sec (18) and ku: 4 x
105 dm /mole-sec (E. D. Clarke, personal communica-
tion).
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tion).
ArNO21 is, of course, protonated at pH 7 and this
recalls a note of caution (50) concerming the potential
reactivity of ArNO21. Since HOi is several orders of
magnitude more reactive than 02 in some circumstan-
ces (102), it is possible that the protonated conjugate of
ArNO2 may play a role in its biological activity.
Conclusions
Although adetailedunderstanding ofthemechanisms
of cytotoxicity of nitroaryl compounds in both procar-
yotic and eucaryotic cells still eludes us, there is no
question that the use of these compounds in medicine
andcancertherapyreliesuponfree-radicalmechanisms.
Theredoxproperties oftheone-electroncouple: ArNO2/
ArNO2" define virtually all the biological properties of
these compounds. Disproportionation of the radicals
controls their natural lifetime in most model chemical
and biological systems (though with important excep-
tions). In all cases, the rates of these natural radical-
decay processes is a function ofpH and the prototropic
properties ofthe radical. Most simple electron-transfer
reactions can be rationalized in terms of both equilib-
rium and kinetics.
However, there are still many, important questions
unanswered. There are some parallels in the chemistry
ofArNO2" andO2-. Theenormous, widespreadinterest
inthebiologicalroleof02- is somewhatparadoxial since
O2- itselfis really rather an unrective species. It seems
that ArNO21 is even less reactive than O2- towards
likely biological targets (except ofcourse readily defin-
able electron acceptors). It is hoped that this short ar-
ticle will help clarify the likely role of nitro radicals in
biological systems and help point experimentalists to-
wards identifying the critical reactions, which maywell
involve ArNO2~as an obligate intermediate but prob-
ably not as the direct, damaging toxin.
This work was supported by the Cancer Research Campaign.
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